69 results
8-K
EX-99.1
LBPH
Longboard Pharmaceuticals, Inc.
1 Aug 24
Longboard Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
4:10pm
. For such statements, Longboard claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from … risks related to Longboard’s dependence on third parties; competition; product liability or other litigation or disagreements with others; government
8-K
EX-99.2
LBPH
Longboard Pharmaceuticals, Inc.
1 Aug 24
Longboard Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
4:10pm
” and similar words. For such statements, we claim the protection of the Private Securities Litigation Reform Act of 1995. These forward-looking
8-K
EX-99.1
LBPH
Longboard Pharmaceuticals, Inc.
1 Jul 24
Regulation FD Disclosure
9:15am
and Longboard’s Phase 1 SAD clinical trial for LP659. For such statements, Longboard claims the protection of the Private Securities Litigation … litigation or disagreements with others; government and third-party payor actions, including relating to reimbursement and pricing; risks related
8-K
LBPH
Longboard Pharmaceuticals, Inc.
1 Jul 24
Regulation FD Disclosure
9:15am
within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this Current Report on Form 8-K … arrangements; other risks related to Longboard's dependence on third parties; competition; product liability or other litigation or disagreements
8-K
9qp6yb 6t0shp8m0dxe
10 Jun 24
Regulation FD Disclosure
9:05am
8-K
EX-99.2
kq8irpd8y
10 Jun 24
Regulation FD Disclosure
9:05am
8-K
EX-99.1
etwz65iyp
10 Jun 24
Regulation FD Disclosure
9:05am
8-K
EX-99.1
coibhomweaticyggf
2 May 24
Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates
4:10pm
S-3ASR
EX-4.5
504sxnvld6dhbeu eno
12 Mar 24
Automatic shelf registration
4:45pm
8-K
EX-99.2
10ex80kdrrbe8khp
12 Mar 24
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
4:10pm
8-K
EX-99.1
k5t63u prz
12 Mar 24
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
4:10pm
8-K
EX-1.1
yc42j 99tl7
4 Jan 24
Other Events
4:51pm
8-K
jps ibmmyb
4 Jan 24
Other Events
4:51pm
424B5
klsl5j x9c
4 Jan 24
Prospectus supplement for primary offering
4:48pm
424B5
a92xmbk
2 Jan 24
Prospectus supplement for primary offering
4:54pm
8-K
uo9jeqzn
2 Jan 24
Results of Operations and Financial Condition
4:02pm